Some are, including GLP-1 receptor agonists (semaglutide, tirzepatide), insulin, and a range of hormone-based therapeutics
Last quarter alone, its two leading GLP-1 drugs, Mounjaro and Zepbound, generated a combined $5.4 billion in revenue
Regulatory & Legal Notice This product: Is not a medicinal product under the Human Medicines Regulations 2012 Is not authorised or approved by the MHRA Is not intended for human or veterinary use Is not for clinical, diagnostic, or therapeutic application By purchasing this product, the buyer represents and warrants that it will be used solely for lawful laboratory research purposes and in full compliance with all applicable regulatory and institutional requirements
Which is why Im adding another old wives tale to the list
At Maggio Law, we understand the challenges those affected by GLP-1 medications face and are committed to advocating for their rights
Also see our reviews of Rice , Oats , and Farrow & Bulgur